Search research articles
Contact Us
Filters
Showing results (61-70 of 418) with videos related to
Page
of 42
Sort By:
The British Journal of Radiology
|
February 28, 2020
Magnetic resonance imaging assessment of chemotherapy-related adipocytic maturation in myxoid/round cell liposarcomas: specificity and prognostic value
Amandine Crombe, Maxime Sitbon, Eberhard Stoeckle, et al.
Oncotarget
|
December 22, 2016
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
Benjamin Fourneaux, Vanessa Chaire, Carlo Lucchesi, et al.
Nature Reviews. Clinical Oncology
|
April 2, 2022
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
Wolf H Fridman, Maxime Meylan, Florent Petitprez, et al.
JAMA Oncology
|
May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy
Carlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
Cells
|
June 2, 2021
Targeting the VEGF Pathway in Osteosarcoma
Tarek Assi, Sarah Watson, Bachar Samra, et al.
BMC Cancer
|
October 15, 2015
PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
Thomas Grellety, Audrey Laroche-Clary, Vanessa Chaire, et al.
Diagnostic and Interventional Imaging
|
October 6, 2023
Radiomics and artificial intelligence for soft-tissue sarcomas: Current status and perspectives
Amandine Crombé, Paolo Spinnato, Antoine Italiano, et al.
Journal of Hematology & Oncology
|
June 21, 2017
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
Audrey Laroche-Clary, Vanessa Chaire, Marie-Paule Algeo, et al.
Virchows Archiv : an International Journal of Pathology
|
July 13, 2016
Challenging a dogma: co-mutations exist in MAPK pathway genes in colorectal cancer
Thomas Grellety, Audrey Gros, Florence Pedeutour, et al.
Cancer Treatment Reviews
|
October 7, 2016
Trabectedin as a chemotherapy option for patients with BRCA deficiency
Bradley J Monk, Domenica Lorusso, Antoine Italiano, et al.
Page
of 42
Search research articles
Search
Showing results (61-70 of 418) with videos related to
Sort By:
Page
of 42
The British Journal of Radiology
|
February 28, 2020
Magnetic resonance imaging assessment of chemotherapy-related adipocytic maturation in myxoid/round cell liposarcomas: specificity and prognostic value
Amandine Crombe, Maxime Sitbon, Eberhard Stoeckle, et al.
Oncotarget
|
December 22, 2016
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
Benjamin Fourneaux, Vanessa Chaire, Carlo Lucchesi, et al.
Nature Reviews. Clinical Oncology
|
April 2, 2022
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
Wolf H Fridman, Maxime Meylan, Florent Petitprez, et al.
JAMA Oncology
|
May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy
Carlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
Cells
|
June 2, 2021
Targeting the VEGF Pathway in Osteosarcoma
Tarek Assi, Sarah Watson, Bachar Samra, et al.
BMC Cancer
|
October 15, 2015
PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
Thomas Grellety, Audrey Laroche-Clary, Vanessa Chaire, et al.
Diagnostic and Interventional Imaging
|
October 6, 2023
Radiomics and artificial intelligence for soft-tissue sarcomas: Current status and perspectives
Amandine Crombé, Paolo Spinnato, Antoine Italiano, et al.
Journal of Hematology & Oncology
|
June 21, 2017
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
Audrey Laroche-Clary, Vanessa Chaire, Marie-Paule Algeo, et al.
Virchows Archiv : an International Journal of Pathology
|
July 13, 2016
Challenging a dogma: co-mutations exist in MAPK pathway genes in colorectal cancer
Thomas Grellety, Audrey Gros, Florence Pedeutour, et al.
Cancer Treatment Reviews
|
October 7, 2016
Trabectedin as a chemotherapy option for patients with BRCA deficiency
Bradley J Monk, Domenica Lorusso, Antoine Italiano, et al.
Page
of 42